Central Bancompany debuted on NASDAQ in November 2025 and is rated a cautious Buy despite trading at a premium to peers. CBC ...

Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...

By comparison, Target's 4.5% yield looks far more attractive, noting that it also comes along with a roughly 55% dividend ...

While tobacco giant Altria Group (MO) understandably may not be everyone’s cup of tea, its relevance cannot be denied.

Altria Group, Inc. ( NYSE:MO ) is about to trade ex-dividend in the next four days. The ex-dividend date is usually ...

If you are wondering whether Altria Group is still a cash rich, undervalued dividend giant or if the easy money has already been made, this breakdown will help you consider whether MO still deserves a ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

These five stocks yield 7% or more but are typically forgotten by growth and income investors. It might be time to take a ...

The millsite price of molasses has plunged by nearly 58 percent to around P7,100 per metric ton (MT) year-on-year amid a supply glut despite the ban on shipments of the raw sugar byproduct. Data from ...

AUSTIN, TEXAS — Since its initial public offering (IPO) in 2020, Vital Farms Inc. has become the largest pasture-raised egg ...

Lee Enterprises, Incorporated (the “Company” and Nasdaq: LEE) today announced that it has entered into a definitive stock purchase agreement for a $50 million strategic equity investment in the ...